Full Text View
Tabular View
No Study Results Posted
Related Studies
Nicotine Replacement Therapy in the Intensive Care Unit (NicGoWell)
This study is currently recruiting participants.
Verified November 2012 by Gelderse Vallei Hospital
Study NCT01362959   Information provided by Gelderse Vallei Hospital

First Received on May 26, 2011.   Last Updated on November 1, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Delirium
Psychomotor Agitation
Substance Withdrawal Syndrome
Nicotine Replacement Therapy
More general conditions related to this trial
Confusion
Delirium, Dementia, Amnestic, Cognitive Disorders
Dyskinesias
Mental Disorders
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Psychomotor Disorders
Signs and Symptoms
Substance-Related Disorders
Interventions listed in this trial
Transdermal nicotine patch
Additional drug interventions recognized in this trial
Nicotine
Nicotine polacrilex
More general drug interventions related to this trial
Autonomic Agents
Central Nervous System Agents
Central Nervous System Stimulants
Cholinergic Agents
Cholinergic Agonists
Ganglionic Stimulants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Nicotinic Agonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Gelderse Vallei Hospital
Wageningen University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services